Since the entry into force of Regulations (EU) 2017/745 (MDR) and (EU) 2017/746 (IVDR) came into effect, European authorities have been closely monitoring the impact of these new requirements on the availability of medical devices (MDs) and in vitro diagnostic medical devices (IVDMDs).